Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) FCF Margin: 2014-2025

Historic FCF Margin for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to 7.77%.

  • Surgery Partners' FCF Margin rose 19300.0% to 7.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.9%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 6.73% for FY2024, which is 7400.0% down from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' FCF Margin is 7.77%, which was up 19300.0% from 7.01% recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' FCF Margin peaked at 12.71% during Q3 2023, and registered a low of 2.19% during Q4 2022.
  • Moreover, its 5-year median value for FCF Margin was 5.82% (2023), whereas its average is 4.63%.
  • As far as peak fluctuations go, Surgery Partners' FCF Margin plummeted by -484500bps in 2021, and later skyrocketed by 107200bps in 2023.
  • Surgery Partners' FCF Margin (Quarter) stood at 0.92% in 2021, then crashed by -339bps to 2.19% in 2022, then skyrocketed by 366bps to 5.82% in 2023, then skyrocketed by 77bps to 10.31% in 2024, then decreased by -25bps to 7.77% in 2025.
  • Its FCF Margin was 7.77% in Q3 2025, compared to 7.01% in Q2 2025 and 2.15% in Q1 2025.